Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine plus short-course radiotherapy in elderly patients with high grade glioma
2012-000091-41Phase 2Terminated
- Sponsor
- University College London
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of hydroxychloroquine in high-grade glioma (HGG), glioma and brain cancer (2 arms), sponsored by University College London. Primary endpoint: One-year survival. Started Jul 2012; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
high-grade glioma (HGG)gliomabrain cancer
Beyond the preview
Go deeper on 2012-000091-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000091-41.